Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma | Conference Paper individual record
author list (cited authors)
Mazumdar, T., Kalu, N. N., Peng, S., Tong, P., Shen, L. i., Wang, J., ... Johnson, F. M.
publication date
2018
published in